Although CCL11 has been demonstrated to be increased in patients with diabetes and obesity, further research is needed to establish the role of CCL11 in diabetic neuropathy and obesity-induced hypersensitivity. Here, CCL11 is linked to obesity due to melanocortin 4 receptor deficiency.